Home › Cerebral Hemorrhage › NCT07651631
Rapid Evacuation and Access of Cerebral Hemorrhage Registry
RecruitingObservational study
A Prospective, Multicenter, Global Registry Evaluating Minimally Invasive Surgery for the Treatment of Acute Spontaneous Supratentorial Intracerebral Hemorrhage.
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Head CT demonstrating an acute, spontaneous, intracerebral hemorrhage * Hemorrhage volume ≥ 20 mLs * Minimally invasive surgical intervention performed within 7 days of hemorrhage Exclusion Criteria: * Ruptured aneurysm, arteriovenous malformation (AVM), vascular anomaly, moyamoya disease, venous sinus thrombosis, mass or tumor, hemorrhagic conversion of an ischemic infarct, recurrence of a recent ICH (\<1 year), as diagnosed with radiographic imaging * Infratentorial intraparenchymal hemorrhage, including midbrain, pontine, or cerebellum * Initial hospital arrival ≥ 24 hours after the onset of stroke symptoms * Last known normal is unknown * Historical Modified Rankin Score \> 4 * Known life-expectancy of less than 1 year prior to ICH * DNR or comfort measures only * Known pregnancy in female subjects * Inability or unwillingness of subject or legal guardian/representative to give written informed consent within 7 days of initial hospital arrival * Inability to meet follow up requiremen
About the study
The goal of this observational study is to quantify the real-world effect of minimally invasive surgery (MIS) in patients with acute spontaneous supratentorial intracerebral hemorrhage.
Sponsor: Emory University · Participants: 2,500 · Started: Aug 12, 2026
Contact the study team
- Alex Hall, DHSc · Phone: 404-778-1585
Official record on ClinicalTrials.gov — NCT07651631
Locations in the U.S.
| Georgia | Grady Memorial Hospital, Atlanta |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.